Yuko Tanaka

Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study

Rimei Nishimura, Yuko Tanaka, Kazuki Koiwai et al. · Cardiovascular Diabetology · 2015 · 104 citations · Full text

MATRIX METALLOPROTEINASES IN HUMAN DIABETIC AND NONDIABETIC VITREOUS

Ming Jin, Kenji Kashiwagi, Yoko Iizuka et al. · Retina · 2001 · 100 citations

First <i>Streptococcus agalactiae</i> Isolates Highly Resistant to Quinolones, with Point Mutations in <i>gyrA</i> and <i>parC</i>

Yoshiaki Kawamura, Hiromitsu Fujiwara, N. Mishima et al. · Antimicrobial Agents and Chemotherapy · 2003 · 92 citations · Full text

Long‐term treatment with empagliflozin as add‐on to oral antidiabetes therapy in <scp>J</scp> apanese patients with type 2 diabetes mellitus

Eiichi Araki, Yukio Tanizawa, Yuko Tanaka et al. · Diabetes Obesity and Metabolism · 2015 · 65 citations

The indirect pathogenicity of Stenotrophomonas maltophilia

Daisuke Kataoka, Hiromitsu Fujiwara, Tomoko Kawakami et al. · International Journal of Antimicrobial Agents · 2003 · 51 citations

Medical Microbiology, Pathogenesis, Vaginitis +5